• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人尿苷二磷酸葡萄糖醛酸基转移酶对吗啡3-和6-葡萄糖醛酸化的同工型选择性及动力学:UGT2B7非典型葡萄糖醛酸化动力学的证据。

Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.

作者信息

Stone Andrew N, Mackenzie Peter I, Galetin Aleksandra, Houston J Brian, Miners John O

机构信息

Department of Clinical Pharmacology, Flinders Medical Centre, Adelaide, Australia.

出版信息

Drug Metab Dispos. 2003 Sep;31(9):1086-9. doi: 10.1124/dmd.31.9.1086.

DOI:10.1124/dmd.31.9.1086
PMID:12920162
Abstract

Morphine elimination involves UDP-glucuronosyltransferase (UGT) catalyzed conjugation with glucuronic acid to form morphine 3- and 6-glucuronides (M3G and M6G, respectively). It has been proposed that UGT2B7 is the major enzyme involved in these reactions, but there is evidence to suggest that other isoforms also catalyze morphine glucuronidation in man. Thus, we have characterized the selectivity and kinetics of M3G and M6G formation by recombinant human UGTs. UGT 1A1, 1A3, 1A6, 1A8, 1A9, 1A10, and 2B7 all catalyzed M3G formation, but only UGT2B7 formed M6G. The kinetics of M3G formation by the UGT1A family isoforms was consistent with a single enzyme Michaelis-Menten model, with apparent Km values ranging from 2.6 to 37.4 mM. In contrast, M3G and M6G formation by UGT2B7 exhibited atypical kinetics. The atypical kinetics may be described by a model with high- and low-affinity Km values (0.42 and 8.3 mM for M3G, and 0.97 and 7.4 mM for M6G) from fitting to a biphasic Michaelis-Menten model. However, a multisite model with an interaction between two identical binding sites in a negative cooperative manner provides a more realistic approach to modeling these data. According to this model, the respective binding affinities (Ks) for M3G and M6G were 1.76 and 1.41 mM, respectively. These data suggest that M6G formation may be used as a selective probe for UGT2B7 activity, and morphine glucuronidation by UGT2B7 appears to involve the simultaneous binding of two substrate molecules, highlighting the need for careful analysis of morphine glucuronidation kinetics in vitro.

摘要

吗啡的消除涉及尿苷二磷酸葡萄糖醛酸基转移酶(UGT)催化与葡萄糖醛酸结合,形成吗啡3-葡萄糖醛酸苷和6-葡萄糖醛酸苷(分别为M3G和M6G)。有人提出UGT2B7是参与这些反应的主要酶,但有证据表明其他同工型也催化人体中的吗啡葡萄糖醛酸化。因此,我们已对重组人UGT形成M3G和M6G的选择性和动力学进行了表征。UGT 1A1、1A3、1A6、1A8、1A9、1A10和2B7均催化M3G的形成,但只有UGT2B7形成M6G。UGT1A家族同工型形成M3G的动力学与单一酶米氏模型一致,表观Km值范围为2.6至37.4 mM。相比之下,UGT2B7形成M3G和M6G表现出非典型动力学。非典型动力学可以通过拟合双相米氏模型的具有高亲和力和低亲和力Km值(M3G为0.42和8.3 mM,M6G为0.97和7.4 mM)的模型来描述。然而,具有两个相同结合位点以负协同方式相互作用的多位点模型为模拟这些数据提供了更现实的方法。根据该模型,M3G和M6G各自的结合亲和力(Ks)分别为1.76和1.41 mM。这些数据表明,M6G的形成可作为UGT2B7活性的选择性探针,并且UGT2B7催化的吗啡葡萄糖醛酸化似乎涉及两个底物分子的同时结合,这突出了在体外仔细分析吗啡葡萄糖醛酸化动力学的必要性。

相似文献

1
Isoform selectivity and kinetics of morphine 3- and 6-glucuronidation by human udp-glucuronosyltransferases: evidence for atypical glucuronidation kinetics by UGT2B7.人尿苷二磷酸葡萄糖醛酸基转移酶对吗啡3-和6-葡萄糖醛酸化的同工型选择性及动力学:UGT2B7非典型葡萄糖醛酸化动力学的证据。
Drug Metab Dispos. 2003 Sep;31(9):1086-9. doi: 10.1124/dmd.31.9.1086.
2
Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.吗啡的葡萄糖醛酸化和葡萄糖苷化代表互补的代谢途径,均由 UDP-葡糖醛酸基转移酶 2B7 催化:动力学、抑制和分子建模研究。
J Pharmacol Exp Ther. 2014 Apr;349(1):126-37. doi: 10.1124/jpet.113.212258. Epub 2014 Jan 23.
3
Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties.尿苷二磷酸葡萄糖醛酸基转移酶1A1和1A8对吗啡-6-葡萄糖醛酸化的贡献及其动力学特性。
Drug Metab Dispos. 2008 Apr;36(4):688-94. doi: 10.1124/dmd.107.019281. Epub 2008 Jan 10.
4
S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.人肝微粒体和重组人尿苷二磷酸葡萄糖醛酸基转移酶(UGT)对S-萘普生和去甲基萘普生的葡萄糖醛酸化作用:UGT2B7在萘普生消除中的作用
Br J Clin Pharmacol. 2005 Oct;60(4):423-33. doi: 10.1111/j.1365-2125.2005.02446.x.
5
The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.二聚化的人UGT2B7、1A1、1A9及其等位基因变体对吗啡的区域选择性葡萄糖醛酸化作用。
Acta Pharmacol Sin. 2017 Aug;38(8):1184-1194. doi: 10.1038/aps.2016.157. Epub 2017 May 29.
6
Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.尿苷二磷酸葡萄糖醛酸基转移酶2B7在人肝脏中对消旋氟比洛芬葡萄糖醛酸化的主要贡献。
Drug Metab Dispos. 2007 Jul;35(7):1182-7. doi: 10.1124/dmd.107.015347. Epub 2007 Apr 19.
7
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.在接受慢性吗啡治疗的癌症患者中,吗啡葡糖醛酸苷与吗啡的血浆比率不受UGT2B7 H268Y和UGT1A1*28基因多态性的影响。
Eur J Clin Pharmacol. 2002 Aug;58(5):353-6. doi: 10.1007/s00228-002-0490-1. Epub 2002 Jul 13.
8
Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.鉴定人 UGT2B7 为参与氯霉素 O-葡萄糖醛酸结合反应的主要同工酶。
Drug Metab Dispos. 2010 Mar;38(3):368-75. doi: 10.1124/dmd.109.029900. Epub 2009 Dec 11.
9
Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.负责双氯芬酸体外葡萄糖醛酸化的大鼠和人类尿苷二磷酸葡萄糖醛酸基转移酶的特性研究。
Toxicol Sci. 2001 May;61(1):49-53. doi: 10.1093/toxsci/61.1.49.
10
Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.评估3'-叠氮-3'-脱氧胸苷、吗啡和可待因作为人肝微粒体中尿苷二磷酸葡萄糖醛酸基转移酶2B7(UGT2B7)的探针底物:UGT2B7*2多态性的特异性及影响
Drug Metab Dispos. 2003 Sep;31(9):1125-33. doi: 10.1124/dmd.31.9.1125.

引用本文的文献

1
A Parent-Metabolite Middle-Out PBPK Model for Genistein and Its Glucuronide Metabolite in Rats: Integrating Liver and Enteric Metabolism with Hepatobiliary and Enteroluminal Transport to Assess Glucuronide Recycling.大鼠中染料木黄酮及其葡萄糖醛酸代谢物的母体-代谢物中间向外PBPK模型:整合肝脏和肠道代谢与肝胆和肠腔转运以评估葡萄糖醛酸循环
Pharmaceutics. 2025 Jun 23;17(7):814. doi: 10.3390/pharmaceutics17070814.
2
Interactive effects of morphine and the HIV integrase inhibitor, cabotegravir, in male and female mice.吗啡与HIV整合酶抑制剂卡博特韦对雄性和雌性小鼠的交互作用。
Biomed Pharmacother. 2025 Mar;184:117925. doi: 10.1016/j.biopha.2025.117925. Epub 2025 Feb 24.
3
Evaluation of the Drug-Drug Interaction Potential of Cannabidiol Against UGT2B7-Mediated Morphine Metabolism Using Physiologically Based Pharmacokinetic Modeling.
使用基于生理的药代动力学模型评估大麻二酚对UGT2B7介导的吗啡代谢的药物-药物相互作用潜力。
Pharmaceutics. 2024 Dec 16;16(12):1599. doi: 10.3390/pharmaceutics16121599.
4
Cannabinoid-Induced Inhibition of Morphine Glucuronidation and the Potential for In Vivo Drug-Drug Interactions.大麻素诱导的吗啡葡萄糖醛酸化抑制作用及体内药物相互作用的可能性。
Pharmaceutics. 2024 Mar 18;16(3):418. doi: 10.3390/pharmaceutics16030418.
5
Hydrocodone, Oxycodone, and Morphine Metabolism and Drug-Drug Interactions.氢可酮、羟考酮和吗啡的代谢与药物相互作用。
J Pharmacol Exp Ther. 2023 Nov;387(2):150-169. doi: 10.1124/jpet.123.001651. Epub 2023 Sep 7.
6
Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk.阿片类药物与维生素C:已知的相互作用及氧化还原信号串扰的可能性
Antioxidants (Basel). 2022 Jun 27;11(7):1267. doi: 10.3390/antiox11071267.
7
Morphine-3-Glucuronide, Physiology and Behavior.吗啡-3-葡萄糖醛酸苷,生理学与行为学
Front Mol Neurosci. 2022 May 12;15:882443. doi: 10.3389/fnmol.2022.882443. eCollection 2022.
8
Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)的酶动力学。
Methods Mol Biol. 2021;2342:301-338. doi: 10.1007/978-1-0716-1554-6_12.
9
Numerical Methods for Modeling Enzyme Kinetics.酶动力学建模的数值方法。
Methods Mol Biol. 2021;2342:147-168. doi: 10.1007/978-1-0716-1554-6_6.
10
Metabolic Profiles of New Unsymmetrical Bisacridine Antitumor Agents in Electrochemical and Enzymatic Noncellular Systems and in Tumor Cells.新型不对称双吖啶抗肿瘤药物在电化学和酶促非细胞体系以及肿瘤细胞中的代谢谱
Pharmaceuticals (Basel). 2021 Apr 1;14(4):317. doi: 10.3390/ph14040317.